ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SYME Supply@me Capital Plc

0.00445
0.00005 (1.14%)
18 Oct 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Supply@me Capital Plc LSE:SYME London Ordinary Share GB00BFMDJC60 ORD 0.002P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00005 1.14% 0.00445 0.004 0.0049 0.0054 0.005 0.01 152,152,399 16:35:29
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Prepackaged Software 842k -4.35M -0.0001 0.00 3.16M
Supply@me Capital Plc is listed in the Prepackaged Software sector of the London Stock Exchange with ticker SYME. The last closing price for Supply@me Capital was 0p. Over the last year, Supply@me Capital shares have traded in a share price range of 0.0029p to 0.094p.

Supply@me Capital currently has 71,732,142,145 shares in issue. The market capitalisation of Supply@me Capital is £3.16 million. Supply@me Capital has a price to earnings ratio (PE ratio) of 0.00.

Supply@me Capital Share Discussion Threads

Showing 6951 to 6969 of 186350 messages
Chat Pages: Latest  290  289  288  287  286  285  284  283  282  281  280  279  Older
DateSubjectAuthorDiscuss
13/9/2020
13:30
Thanks for the update micky.
argo 007
13/9/2020
13:15
Afternoon folks. Well this is now getting ready to start. The British operator in question is StormHarbour Securities LLP, to which the company entrusted the placement of the abs last April (see the press release here) and which is currently negotiating with 16 institutional investors interested in joining the first tranche of the securitization, which concerns the inventory of 40 companies reported to Supply @ Me by its commercial partners (fintech, banks, professional firms, etc.), in what is defined by the company as an open funding approach. In total, the client companies already originated and awaiting the inventory monetization service amounted to 97 (compared to 66 as at 31 December 2019) and the securitization program will cover the entire Supply @ Me portfolio within 12 months. which at the end of 2019 boasted contracts for 970 million euros.
micky67
13/9/2020
12:26
Yip, understand that, was trying to keep it simple, also as we all know the price could do anything at anytime. If there is consolidation I fully expect the price to be in a very positive place beforehand.
yabawbag
13/9/2020
12:09
Has no effect on m cap, just raises the share price, which would increase anyway as more stock monetised.
still waiting
13/9/2020
11:36
Yes I'm thinking 100-1 or 10-1 consolidation if we are lucky. But by that time hopefully the share price will be good enough to hopefully negate this
stccpins
13/9/2020
11:28
Not wanting to put a damp squib on things more a touch of realism. For those hoping "this time next year Rodney we'll be millionaires" don't forget it's almost certain there will be a restructuring of the share capital at some point as discussed on Share Talk during the recent Q&A with AZ.That's not to say it can't or won't happen as anything is possible with SYME however it's worth keeping in the back of your mind!
yabawbag
13/9/2020
11:15
DW it's pointless, hes all over a load of boards with a new username every day, even twice a day at times.Hes also on twitter doing the same.ADVFN need find out who he is and ban him
yabawbag
13/9/2020
10:40
I've deleted my original reply & have sent you a PM Joe.
eggy toast
13/9/2020
10:33
Eggy sorry to harp back to sng. But nobby saya injectable and sng is being inhaled si i would hope coagulation would be less of a chance??? I have small positions sng and syme
joeblogg2
13/9/2020
10:28
I think AZ said end of Sep so have a feeling we still will be waiting for at least a week
yasyas1
13/9/2020
09:57
Past the early part of September this week so after allowing for delays, are we nearly there now?
still waiting
13/9/2020
09:46
I agree. I think it will see an astronomical rise in the very near future.
eggy toast
13/9/2020
09:38
Godd morning everyone, I think the rapid rise of SYME share price will surprise us all !
I'll be adding this month and top slicing at 100p before the end of 2021.
🤑🤑🤑

argo 007
13/9/2020
09:34
Not a problem.

I was merely answering posts put to me.

eggy toast
13/9/2020
09:25
Can we stick to SYME please? If I wanted to know about SNG I would go to their board
cashistrash
13/9/2020
09:03
I'm invested because i know, as do you, that there will be a large rise IF it is PROVEN to be safe.

As for 'the reality is that over 250 patients have received SNG001 and no signal has been seen' i again refer to a far more qualified opinion than that of either you or i.

'Beware of small studies claiming large benefits' Prof Stephen Evans, Professor of Pharmacoepidemiology, London School of Hygiene & Tropical Medicine.

At the moment there is a very real risk that SNG001 will not be approved & it will always be so, until it is approved.

That is FACT Nobby.


Have a nice day.

eggy toast
13/9/2020
08:48
>> eggy toast

God knows why you are an investor in SNG if you are so concerned about this. The reality is that over 250 patients have received SNG001 and no signal has been seen. But don't let the truth get in the way of a good story....

nobbygnome
13/9/2020
08:31
If there is found to be a problem with 'blood coagulation' (that's the real key words Nobby) i think it very unlikely that approval will be given, no matter how 'confident' SNG investors are.

You claimed it was 'nonsense', Prof Stephen Evans, Professor of Pharmacoepidemiology, London School of Hygiene & Tropical Medicine, seems to disagree.

This is why we have drug trials.

eggy toast
13/9/2020
07:12
'Injectable' is the key word. A much higher dose given systemically causes various problems which are not seen by inhalation.

We are in extraordinary times which means normal rules aren't being followed wrt trials and I confidently predict that SNG001 will get emergency approval in various countries. Yes there will be post marketing safety monitoring for the reasons you mention....but approval is coming.

nobbygnome
Chat Pages: Latest  290  289  288  287  286  285  284  283  282  281  280  279  Older

Your Recent History

Delayed Upgrade Clock